List of Tables
    Table 1. Malignant Pleural Mesothelioma Treatment CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Malignant Pleural Mesothelioma Treatment Market Trends
    Table 3. Malignant Pleural Mesothelioma Treatment Market Drivers
    Table 4. Malignant Pleural Mesothelioma Treatment Market Challenges
    Table 5. Malignant Pleural Mesothelioma Treatment Market Restraints
    Table 6. Global Malignant Pleural Mesothelioma Treatment Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Malignant Pleural Mesothelioma Treatment Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Malignant Pleural Mesothelioma Treatment Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Malignant Pleural Mesothelioma Treatment Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Malignant Pleural Mesothelioma Treatment Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Malignant Pleural Mesothelioma Treatment Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Malignant Pleural Mesothelioma Treatment Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Malignant Pleural Mesothelioma Treatment Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Malignant Pleural Mesothelioma Treatment Sales Share by Manufacturer, 2017-2022
    Table 15. Global Malignant Pleural Mesothelioma Treatment Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Malignant Pleural Mesothelioma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Malignant Pleural Mesothelioma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malignant Pleural Mesothelioma Treatment as of 2021)
    Table 18. Top Players of Malignant Pleural Mesothelioma Treatment in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Malignant Pleural Mesothelioma Treatment Product Type
    Table 20. Date of International Manufacturers Enter into Malignant Pleural Mesothelioma Treatment Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Malignant Pleural Mesothelioma Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Malignant Pleural Mesothelioma Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Malignant Pleural Mesothelioma Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Malignant Pleural Mesothelioma Treatment Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Malignant Pleural Mesothelioma Treatment Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Malignant Pleural Mesothelioma Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Malignant Pleural Mesothelioma Treatment Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Malignant Pleural Mesothelioma Treatment Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Malignant Pleural Mesothelioma Treatment Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Malignant Pleural Mesothelioma Treatment Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Malignant Pleural Mesothelioma Treatment Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Malignant Pleural Mesothelioma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Malignant Pleural Mesothelioma Treatment Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Malignant Pleural Mesothelioma Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Malignant Pleural Mesothelioma Treatment Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Malignant Pleural Mesothelioma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Malignant Pleural Mesothelioma Treatment Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Malignant Pleural Mesothelioma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Malignant Pleural Mesothelioma Treatment Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Malignant Pleural Mesothelioma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Eli Lilly Corporation Information
    Table 43. Eli Lilly Description and Business Overview
    Table 44. Eli Lilly Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Eli Lilly Malignant Pleural Mesothelioma Treatment Product
    Table 46. Eli Lilly Recent Development
    Table 47. Teva Corporation Information
    Table 48. Teva Description and Business Overview
    Table 49. Teva Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Teva Product
    Table 51. Teva Recent Development
    Table 52. Sanofi Corporation Information
    Table 53. Sanofi Description and Business Overview
    Table 54. Sanofi Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Sanofi Product
    Table 56. Sanofi Recent Development
    Table 57. Bristol-Myers Squibb Corporation Information
    Table 58. Bristol-Myers Squibb Description and Business Overview
    Table 59. Bristol-Myers Squibb Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Bristol-Myers Squibb Product
    Table 61. Bristol-Myers Squibb Recent Development
    Table 62. Pfizer Corporation Information
    Table 63. Pfizer Description and Business Overview
    Table 64. Pfizer Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Pfizer Product
    Table 66. Pfizer Recent Development
    Table 67. Roche Corporation Information
    Table 68. Roche Description and Business Overview
    Table 69. Roche Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Roche Product
    Table 71. Roche Recent Development
    Table 72. Merck Corporation Information
    Table 73. Merck Description and Business Overview
    Table 74. Merck Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Merck Product
    Table 76. Merck Recent Development
    Table 77. Ono Pharmaceutical Corporation Information
    Table 78. Ono Pharmaceutical Description and Business Overview
    Table 79. Ono Pharmaceutical Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Ono Pharmaceutical Product
    Table 81. Ono Pharmaceutical Recent Development
    Table 82. Mylan Corporation Information
    Table 83. Mylan Description and Business Overview
    Table 84. Mylan Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Mylan Product
    Table 86. Mylan Recent Development
    Table 87. Fresenius Kabi Corporation Information
    Table 88. Fresenius Kabi Description and Business Overview
    Table 89. Fresenius Kabi Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Fresenius Kabi Product
    Table 91. Fresenius Kabi Recent Development
    Table 92. Sun Pharmaceuticals Corporation Information
    Table 93. Sun Pharmaceuticals Description and Business Overview
    Table 94. Sun Pharmaceuticals Malignant Pleural Mesothelioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Sun Pharmaceuticals Product
    Table 96. Sun Pharmaceuticals Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Malignant Pleural Mesothelioma Treatment Customers List
    Table 100. Malignant Pleural Mesothelioma Treatment Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Malignant Pleural Mesothelioma Treatment Product Picture
    Figure 2. Global Malignant Pleural Mesothelioma Treatment Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Malignant Pleural Mesothelioma Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. Global Malignant Pleural Mesothelioma Treatment Sales 2017-2028 (K Units)
    Figure 5. United States Malignant Pleural Mesothelioma Treatment Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Malignant Pleural Mesothelioma Treatment Market Size 2017-2028 (US$ Million)
    Figure 7. United States Malignant Pleural Mesothelioma Treatment Sales 2017-2028 (K Units)
    Figure 8. United States Malignant Pleural Mesothelioma Treatment Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Malignant Pleural Mesothelioma Treatment Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Malignant Pleural Mesothelioma Treatment Report Years Considered
    Figure 11. Product Picture of Pemetrexed
    Figure 12. Product Picture of Cisplatin
    Figure 13. Product Picture of Others
    Figure 14. Global Malignant Pleural Mesothelioma Treatment Market Share by Type in 2022 & 2028
    Figure 15. Global Malignant Pleural Mesothelioma Treatment Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Malignant Pleural Mesothelioma Treatment Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Malignant Pleural Mesothelioma Treatment Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Malignant Pleural Mesothelioma Treatment Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Malignant Pleural Mesothelioma Treatment Price by Type (2017-2028) & (US$/Unit)
    Figure 20. United States Malignant Pleural Mesothelioma Treatment Market Share by Type in 2022 & 2028
    Figure 21. United States Malignant Pleural Mesothelioma Treatment Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Malignant Pleural Mesothelioma Treatment Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Malignant Pleural Mesothelioma Treatment Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Malignant Pleural Mesothelioma Treatment Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Malignant Pleural Mesothelioma Treatment Price by Type (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Clinics
    Figure 28. Product Picture of Others
    Figure 29. Global Malignant Pleural Mesothelioma Treatment Market Share by Application in 2022 & 2028
    Figure 30. Global Malignant Pleural Mesothelioma Treatment Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Malignant Pleural Mesothelioma Treatment Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Malignant Pleural Mesothelioma Treatment Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Malignant Pleural Mesothelioma Treatment Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Malignant Pleural Mesothelioma Treatment Price by Application (2017-2028) & (US$/Unit)
    Figure 35. United States Malignant Pleural Mesothelioma Treatment Market Share by Application in 2022 & 2028
    Figure 36. United States Malignant Pleural Mesothelioma Treatment Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Malignant Pleural Mesothelioma Treatment Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Malignant Pleural Mesothelioma Treatment Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Malignant Pleural Mesothelioma Treatment Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Malignant Pleural Mesothelioma Treatment Price by Application (2017-2028) & (US$/Unit)
    Figure 41. North America Malignant Pleural Mesothelioma Treatment Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Malignant Pleural Mesothelioma Treatment Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Malignant Pleural Mesothelioma Treatment Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Malignant Pleural Mesothelioma Treatment Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Malignant Pleural Mesothelioma Treatment Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Malignant Pleural Mesothelioma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Malignant Pleural Mesothelioma Treatment Value Chain
    Figure 75. Malignant Pleural Mesothelioma Treatment Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed